Gerber Kawasaki Wealth & Investment Management
Source: SEC Form 13F · as of Mar 2026Gerber Kawasaki Wealth & Investment Management holds 13 biotech & pharma companies tracked by BioSniper, totaling $21.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$21.8M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 13,932 | $12.8M |
| AMGNAMGEN INC | 7,505 | $2.6M |
| JNJJOHNSON & JOHNSON | 5,418 | $1.3M |
| ABBVAbbVie Inc. | 4,932 | $1.1M |
| CRSPCRISPR Therapeutics AG | 20,460 | $973K |
| MRKMerck & Co., Inc. | 5,664 | $681K |
| DGXQuest Diagnostics Incorporated | 3,198 | $625K |
| PFEPFIZER INC | 21,442 | $602K |
| PMPhilip Morris International Inc | 2,003 | $331K |
| ABTABBOTT LABORATORIES | 3,219 | $331K |
| IDXXIDEXX LABORATORIES INC /DE | 461 | $259K |
| OCGNOcugen, Inc. | 69,348 | $126K |
| CYPHCYPHERPUNK TECHNOLOGIES INC. | 22,000 | $17K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.